Schizophrenia (SZC) is a common, chronic, and severe mental illness. Recent years have witnessed increased study into the link between gut microbiome and psychotic disorders, particularly schizophrenia. Focusing on inflammatory, tryptophan compounds, and BDNF concentrations, we examine the data that currently exists linking intestinal microbiota to schizophrenia and explain how the presumptive dysregulation could fit into accepted theories of the disease's pathophysiology. We looked at recent research and assessed the therapeutic possibility of modifying the intestinal microbiota with prebiotics as adjuvant therapy for schizophrenia. Overall, although the available information on microbiome changes in schizophrenia is extremely erratic and inadequate to draw any firm conclusions. There were successful attempts that decreased the risk of SCZ by interfering with the intestinal microbiota. The gut microbiota is a possible approach to the treatment of schizophrenia.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.